Louis Matis - Net Worth and Insider Trading
Louis Matis Net Worth
The estimated net worth of Louis Matis is at least $2,124 dollars as of 2024-09-20. Louis Matis is the SVP, Chief Development Officer of Pieris Pharmaceuticals Inc and owns about 125 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $2,124. Details can be seen in Louis Matis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louis Matis has not made any transactions after 2016-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Louis Matis
Louis Matis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Louis Matis owns 1 companies in total, including Pieris Pharmaceuticals Inc (PIRS) .
Click here to see the complete history of Louis Matis’s form 4 insider trades.
Insider Ownership Summary of Louis Matis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2016-06-14 | SVP & Chief Development Officer |
Louis Matis Latest Holdings Summary
Louis Matis currently owns a total of 1 stock. Louis Matis owns 125 shares of Pieris Pharmaceuticals Inc (PIRS) as of June 14, 2016, with a value of $2,124.
Latest Holdings of Louis Matis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2016-06-14 | 125 | 16.99 | 2,124 |
Holding Weightings of Louis Matis
Louis Matis Form 4 Trading Tracker
According to the SEC Form 4 filings, Louis Matis has made a total of 0 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years. The most-recent trade in Pieris Pharmaceuticals Inc is the acquisition of 125 shares on June 14, 2016, which cost Louis Matis around $17,000.
Insider Trading History of Louis Matis
- 1
Louis Matis Trading Performance
GuruFocus tracks the stock performance after each of Louis Matis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis Matis is -4.27%. GuruFocus also compares Louis Matis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis Matis within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Louis Matis's insider trading performs compared to the benchmark.
Performance of Louis Matis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.49 | | | | | |
| Relative Return to S&P 500(%) | 1.23 | | | | | |
Louis Matis Ownership Network
Louis Matis Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Louis Matis is the SVP & Chief Development Officer of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Louis Matis made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 10,000 shares made by Christopher P Kiritsy , and a net purchase of 6,000 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 6,000 shares, with a net purchase of 6,000 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,125 shares were bought by its insiders, resulting in a net purchase of 6,125 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Louis Matis Mailing Address
Above is the net worth, insider trading, and ownership report for Louis Matis. You might contact Louis Matis via mailing address: Lise-meitner-strasse 30, C/o Pieris Pharmaceuticals, Inc., Freising-weihenstephan 2m 85354.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
